Cross-linking was pioneered in 1997 and eventually approved by the FDA in 2016. It is an office-based procedure that can slow, stop, and often reverse the effects of Keratoconus and post-LASIK ectasia. Patients should expect their corrected and uncorrected vision to improve and their risk of requiring corneal transplantation to decrease. As one of the original Avedro FDA investigation sites, our office performs cross-linking in a sterile, climate controlled operating suite using the latest technology.
Most major insurance companies cover cross-linking. For patients without adequate health policies we employ special programs and secure industry support to assure this vision preserving technology is available in all appropriate cases.
James S. Lewis, MD, a fellowship trained corneal specialist, has performed collagen cross-linking for over a decade. Patrick McManamon, OD, a highly experienced scleral lens expert, has extensive experience managing keratoconus and LASIK ectasia patients. Patients can select either in-house post-operative management or post-procedure care from their referring eye physician.
Nicholas Gidosh, OD, Chief of the Cornea and Contact Lens Division of Salus University (formerly the Pennsylvania College of Optometry) uses our facility exclusively. This close relationship provides all cross-linking patients access to a broad range of specialists and scientists as well as groundbreaking technology only available in a research institution.
Beyond cross-linking our practice offers complex scleral, RGP, and hybrid contact lens fits as well as topology guided excimer laser corneal reshaping. Furthermore, we have programs for traditional epithelium-off cross-linking and a less invasive epithelium-on variant. As the first practice in Pennsylvania to perform Staar’s Visian ICL (Intraocular Collamer Lens), we now offer Toric Visian ICL’s for additional visual rehabilitation.
Contact our office for a cross-linking evaluation.
215-886-9090
8380 Old York Road, Suite 110A
Elkins Park, PA 19027